AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment - Top-Institutions - MDSpire

AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

  • By

  • Andrea Surnit

  • May 29, 2026

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Stanford NSCLC Radiogenomics
    Stanford NSCLC Radiogenomics

    Stanford, CA

    Key Differentiators

    • Oncology

  • #3

    Institute for Cancer Research, Oslo University Hospital
    Institute for Cancer Research, Oslo University Hospital

    Oslo, Norway

    Key Differentiators

    • Oncology

  • #4

    University College London Hospitals NHS Foundation Trust
    University College London Hospitals NHS Foundation Trust

    London, UK

    Key Differentiators

    • Oncology

  • #5

    Guangdong Provincial People’s Hospital
    Guangdong Provincial People’s Hospital

    Guangdong, China

    Key Differentiators

    • Oncology

Original Source(s)

AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

  • by Andrea Surnit

  • May 29, 2026

Related Content

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West Indies

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.